Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

SUCCESSFUL TREATMENT OF. JUVENILE CHRONIC ARTHRITIS WITH A SPECIFIC ANTIVIRAL AGENT

Identifieur interne : 002143 ( Main/Exploration ); précédent : 002142; suivant : 002144

SUCCESSFUL TREATMENT OF. JUVENILE CHRONIC ARTHRITIS WITH A SPECIFIC ANTIVIRAL AGENT

Auteurs : M. H. Pritchard ; Julia Munro

Source :

RBID : ISTEX:759B8DCDC9B61A0AFE15BB6BAD90C7C947E5A40A

Descripteurs français

English descriptors

Abstract

In a previous paper we identified a group of patients with teenage onset chronic progressive arthritis (JCA or JRA) with raised antibody titres to influenza A (H2N2), an epidemic of which was present in the year they were born. On the basis that they might be chronic carriers of influenza A, and that this might be related to their arthropathy, it was decided to use the anti-influenza A drug amantadine to treat the virus and observe whether there was any effect on the joint disease. A 4-month, double-blind, placebo-controlled trial followed by a 4-month open study showed that amantadine could under these circumstances be of considerable therapeutic benefit while having no effect on patients without elevated antibody titres against influenza A.

Url:
DOI: 10.1093/rheumatology/28.6.521


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>SUCCESSFUL TREATMENT OF. JUVENILE CHRONIC ARTHRITIS WITH A SPECIFIC ANTIVIRAL AGENT</title>
<author>
<name sortKey="Pritchard, M H" sort="Pritchard, M H" uniqKey="Pritchard M" first="M. H." last="Pritchard">M. H. Pritchard</name>
</author>
<author>
<name sortKey="Munro, Julia" sort="Munro, Julia" uniqKey="Munro J" first="Julia" last="Munro">Julia Munro</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:759B8DCDC9B61A0AFE15BB6BAD90C7C947E5A40A</idno>
<date when="1989" year="1989">1989</date>
<idno type="doi">10.1093/rheumatology/28.6.521</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-R313BCLF-V/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001070</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001070</idno>
<idno type="wicri:Area/Istex/Curation">001070</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E64</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000E64</idno>
<idno type="wicri:doubleKey">1462-0324:1989:Pritchard M:successful:treatment:of</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:2590807</idno>
<idno type="wicri:Area/PubMed/Corpus">000459</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000459</idno>
<idno type="wicri:Area/PubMed/Curation">000459</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000459</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000410</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000410</idno>
<idno type="wicri:Area/Ncbi/Merge">000B59</idno>
<idno type="wicri:Area/Ncbi/Curation">000B59</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B59</idno>
<idno type="wicri:doubleKey">0263-7103:1989:Pritchard M:successful:treatment:of</idno>
<idno type="wicri:Area/Main/Merge">002247</idno>
<idno type="wicri:Area/Main/Curation">002143</idno>
<idno type="wicri:Area/Main/Exploration">002143</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">SUCCESSFUL TREATMENT OF. JUVENILE CHRONIC ARTHRITIS WITH A SPECIFIC ANTIVIRAL AGENT</title>
<author>
<name sortKey="Pritchard, M H" sort="Pritchard, M H" uniqKey="Pritchard M" first="M. H." last="Pritchard">M. H. Pritchard</name>
<affiliation></affiliation>
<affiliation>
<wicri:noCountry code="no comma">Correspondence to Dr. Pritchard.</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Munro, Julia" sort="Munro, Julia" uniqKey="Munro J" first="Julia" last="Munro">Julia Munro</name>
<affiliation>
<wicri:noCountry code="subField">Wales</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Rheumatology</title>
<idno type="eISSN">1462-0332</idno>
<idno type="ISSN">1462-0324</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date when="1989-12">1989</date>
<biblScope unit="vol">28</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="521">521</biblScope>
<biblScope unit="page" to="524">524</biblScope>
</imprint>
<idno type="ISSN">1462-0324</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1462-0324</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Amantadine (therapeutic use)</term>
<term>Antibodies, Viral (analysis)</term>
<term>Arthritis, Juvenile (blood)</term>
<term>Arthritis, Juvenile (drug therapy)</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Humans</term>
<term>Influenza A virus (immunology)</term>
<term>Placebos</term>
<term>Recurrence</term>
<term>Remission Induction</term>
<term>Rheumatoid Factor (analysis)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Amantadine (usage thérapeutique)</term>
<term>Anticorps antiviraux (analyse)</term>
<term>Arthrite juvénile (sang)</term>
<term>Arthrite juvénile (traitement médicamenteux)</term>
<term>Facteur rhumatoïde (analyse)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Induction de rémission</term>
<term>Méthode en double aveugle</term>
<term>Placebo</term>
<term>Récidive</term>
<term>Virus de la grippe A (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Antibodies, Viral</term>
<term>Rheumatoid Factor</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Amantadine</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Anticorps antiviraux</term>
<term>Facteur rhumatoïde</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en">
<term>Arthritis, Juvenile</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Arthritis, Juvenile</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Arthrite juvénile</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Arthrite juvénile</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Amantadine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Humans</term>
<term>Placebos</term>
<term>Recurrence</term>
<term>Remission Induction</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Femelle</term>
<term>Humains</term>
<term>Induction de rémission</term>
<term>Méthode en double aveugle</term>
<term>Placebo</term>
<term>Récidive</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">In a previous paper we identified a group of patients with teenage onset chronic progressive arthritis (JCA or JRA) with raised antibody titres to influenza A (H2N2), an epidemic of which was present in the year they were born. On the basis that they might be chronic carriers of influenza A, and that this might be related to their arthropathy, it was decided to use the anti-influenza A drug amantadine to treat the virus and observe whether there was any effect on the joint disease. A 4-month, double-blind, placebo-controlled trial followed by a 4-month open study showed that amantadine could under these circumstances be of considerable therapeutic benefit while having no effect on patients without elevated antibody titres against influenza A.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Munro, Julia" sort="Munro, Julia" uniqKey="Munro J" first="Julia" last="Munro">Julia Munro</name>
<name sortKey="Pritchard, M H" sort="Pritchard, M H" uniqKey="Pritchard M" first="M. H." last="Pritchard">M. H. Pritchard</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002143 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002143 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:759B8DCDC9B61A0AFE15BB6BAD90C7C947E5A40A
   |texte=   SUCCESSFUL TREATMENT OF. JUVENILE CHRONIC ARTHRITIS WITH A SPECIFIC ANTIVIRAL AGENT
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021